Close Menu

NEW YORK (360Dx) – Bio-Rad Laboratories announced today its assay for Lyme disease has received clearance from the US Food and Drug Administration.

The Lyme Total Assay is an immunoassay that detects multiple targets using ligand-coated beads. It runs on the firm's BioPlex 2200 System, an automated and random-access multiplex platform.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.